Health Times Cambodia: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Times Cambodia.

Press releases published on August 31, 2026

22 minutes ago

AIM ImmunoTech Secures Broad U.S. Patent for Rintatolimod (Ampligen®) Used in Combination with Pembrolizumab (Keytruda®), Expanding Oncology IP Protection for Ampligen Through 2039

Indeterminate GlobeNewswire

23 minutes ago

Profusa, Inc. Announces Compliance with Nasdaq Publicly Held Shares Requirement

Indeterminate GlobeNewswire

29 minutes ago

Daré Bioscience Announces New NIH Funding Award for Approximately $908,000 to Advance DARE-PTB2 for the Prevention of Preterm Birth

Indeterminate GlobeNewswire

38 minutes ago

OneMedNet’s iRWD Platform Enables Rapid Feasibility-to-Delivery for Leading AI-Driven Drug Development Company

Indeterminate GlobeNewswire

43 minutes ago

Lexicon Announces New Post Hoc SOLOIST-WHF Analysis Demonstrating Consistent Sotagliflozin Results Across Baseline Blood Pressure Levels in Patients with Recent Worsening Heart Failure

Indeterminate GlobeNewswire

43 minutes ago

Allogene Therapeutics Announces Participation in September Investor Conference

Indeterminate GlobeNewswire

43 minutes ago

Chloe Kim Teams Up with Qelbree®, the #1 Prescribed Branded Non-Stimulant ADHD Treatment*, to Help Empower People Navigating ADHD

Indeterminate GlobeNewswire

an hour ago

Arch Biopartners Receives Central IRB Approval to Support U.S. Sites in Phase II Cardiac Surgery-Associated Acute Kidney Injury Trial of LSALT Peptide

Indeterminate GlobeNewswire

an hour ago

Amarin Highlights New REDUCE-IT® and Mechanistic Data Presented at European Society of Cardiology (ESC) Congress 2026

Indeterminate GlobeNewswire

an hour ago

Elicio Therapeutics to Participate at the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

an hour ago

Sofwave Announces Publication of Data from Randomized Controlled Study of its Pure Impact™ VIP Platform Utilizing PlyoPulse™ EMS Technology in Aesthetic Surgery Journal

Indeterminate GlobeNewswire

an hour ago

OnKure Therapeutics to Participate in the Morgan Stanley Global Healthcare Conference

Indeterminate GlobeNewswire

an hour ago

Cadrenal Therapeutics Announces Positive Outcome from FDA Type D Meeting for Phase 3 Registration Study of CAD-1005 in Heparin-Induced Thrombocytopenia

Indeterminate GlobeNewswire

an hour ago

Beyond Air® Receives FDA Breakthrough Device Designation for LungFit® GO to Treat Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD)

Indeterminate GlobeNewswire

an hour ago

AEON Biopharma to Participate in Lake Street Capital Markets’ 10th Annual Best Ideas Growth (BIG10) Conference

Indeterminate GlobeNewswire

an hour ago

BioVie Announces Completion of Treatment Phase of ADDRESS-LC Trial of Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID

Indeterminate GlobeNewswire

an hour ago

Revelyx Bio Launches to Advance YY003, an Investigational Recombinant Botulinum Toxin Type A in a Ready-to-Use Liquid Formulation

Indeterminate GlobeNewswire

an hour ago

ORYZON Announces Notice of Allowance for U.S. Patent Application Covering Iadademstat Combination With Gilteritinib

Indeterminate GlobeNewswire

an hour ago

Teladoc Health Appoints Michael Grasher as Chief Financial Officer

Indeterminate GlobeNewswire

an hour ago

Chemomab Therapeutics to Present at H.C. Wainwright 28th Annual Global Investor Conference

Indeterminate GlobeNewswire